ID: ALA414972

Max Phase: Preclinical

Molecular Formula: C90H104N13O15S2+

Molecular Weight: 1672.03

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H](NC(=O)[C@H]1CSSC[C@H](NC(=O)[C@@H](Cc2ccccc2)NNC(=O)CC[N+]2=C(/C=C/C=C/C=C/C=C3/N(CCC(=O)O)c4ccc5ccccc5c4C3(C)C)C(C)(C)c3c2ccc2ccccc32)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N1)C(=O)O

Standard InChI:  InChI=1S/C90H103N13O15S2/c1-53(104)79-87(116)97-70(86(115)99-80(54(2)105)88(117)118)52-120-119-51-69(85(114)94-66(47-56-34-38-60(106)39-35-56)82(111)95-67(49-59-50-92-64-30-20-19-27-61(59)64)83(112)93-65(81(110)98-79)31-21-22-44-91)96-84(113)68(48-55-23-11-10-12-24-55)100-101-75(107)42-45-102-71-40-36-57-25-15-17-28-62(57)77(71)89(3,4)73(102)32-13-8-7-9-14-33-74-90(5,6)78-63-29-18-16-26-58(63)37-41-72(78)103(74)46-43-76(108)109/h7-20,23-30,32-41,50,53-54,65-70,79-80,92,100,104-105H,21-22,31,42-49,51-52,91H2,1-6H3,(H10-,93,94,95,96,97,98,99,101,106,107,108,109,110,111,112,113,114,115,116,117,118)/p+1/t53-,54-,65+,66+,67-,68-,69+,70-,79-,80+/m1/s1

Standard InChI Key:  XMIAOODMIJLAHW-HXWWZQOFSA-O

Associated Targets(non-human)

Somatostatin receptor 172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1672.03Molecular Weight (Monoisotopic): 1670.7211AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL..  (2002)  Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.,  45  (10): [PMID:11985468] [10.1021/jm010519l]

Source